ArticleNature cancer2025

CHD1 loss reprograms SREBP2-driven cholesterol synthesis to fuel androgen-responsive growth and castration resistance in SPOP-mutated prostate tumors.

Feiyu Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.